 Announces Regulatory and Compliance Advisory Board DORADO, PUERTO RICO ACCESSWIRE June 14, 2021 Pharma-Bio Serv, Inc. Pharma-Bio Serv or the Company OTCQB:PBSV, a compliance, project management and technology transfer support consulting firm that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced revenues for the three and six months ended April 30, 2021 were 5,042,000 and 9,530,000, respectively, a decrease of approximately 606,000 and 731,000, respectively, when compared to the same periods last year. Net income for the three and six months ended April 30, 2021 was approximately 240,000 and 508,000, a decrease of approximately 448,000 and 706,000 when compared to the same periods last year, respectively. 